Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of J Steven Leeder in Dermatophytosis Treatment
Introduction: J Steven Leeder, based in Kansas City, MO, is a notable inventor recognized for his significant contributions in the realm of dermatology, particularly in the treatment and prophylaxis of topical fungal infections. With a focus on innovative solutions, he has secured one patent that reflects his dedication to advancing medical treatments.
Latest Patents: Leeder's patent, titled "Dermatophytosis Prophylaxis and Treatment," presents a novel composition and method designed to combat topical fungal infections. This invention involves an HMG-CoA reductase inhibitor combined with a carrier, which can include an anti-fungal agent. The effective method recommends applying the composition topically, either once or multiple times. Furthermore, this treatment can be utilized in conjunction with other forms of fungal treatment, such as oral medications, thereby enhancing its efficacy.
Career Highlights: J Steven Leeder is affiliated with Children’s Mercy Hospital, where he actively engages in research and development to improve patient care. His innovative spirit and dedication have contributed to advancing therapeutic options in dermatology, emphasizing the importance of combining traditional and modern treatment methodologies.
Collaborations: Throughout his career, Leeder has worked alongside esteemed colleagues, including Susan Abdel-Rahman and Barry L Preuett. These collaborations have facilitated a productive environment for innovation, fostering advancements in medical treatments and fostering cross-disciplinary research.
Conclusion: J Steven Leeder's inventive work in dermatology, particularly with his patent for dermatophytosis treatment, underscores the vital role of innovation in healthcare. As he continues to contribute his expertise from Children’s Mercy Hospital, his efforts not only enhance the scientific community's understanding of fungal infections but also significantly improve patient outcomes.